Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Phio Pharmaceuticals Corp. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Phio Pharmaceuticals Corp. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Phio Pharmaceuticals Corp..